These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 4200675

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J, Cordes U, Sell G, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glipizide: experimental study and comparison with other sulfonylureas.
    Loubatieres-Mariani MM.
    Acta Endocrinol Suppl (Copenh); 1980 Dec; 239():26-32. PubMed ID: 6776761
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J, Haupt E, Cordes U, Sell G, Schöffling K.
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
    Marble A.
    Drugs; 1971 Nov; 1(2):109-15. PubMed ID: 4999930
    [No Abstract] [Full Text] [Related]

  • 11. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I, Madsen SN.
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
    Alemany M, Palou A, Codina J, Herrera E.
    Diabete Metab; 1978 Sep; 4(3):181-6. PubMed ID: 101403
    [No Abstract] [Full Text] [Related]

  • 16. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H, Denes A, Girard J, Collard F, Berger W.
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB.
    Journ Annu Diabetol Hotel Dieu; 1984 Sep; ():183-91. PubMed ID: 6443219
    [No Abstract] [Full Text] [Related]

  • 20. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD.
    Clin Pharm; 1984 Sep; 3(5):473-85. PubMed ID: 6435940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.